When compared with the children without asthma, an increasing serum level of C4 component of the complement system is observed in the majority of the patients with intermittent atopic asthma, representing a biomarker for diagnosis of intermittent atopic asthma (52). The gene discussed is C4A; the disease is atopic asthma.